Dan Littman
InvestorVenture Partner at Catalio Capital Management, LP
New York, New York
Writes $100K – $5M checks · typically $1.5M
Find your path to Dan
35 people in our graph share verified history with Dan — schools, employers, funds. One of them is your warm intro.
About
Dan Littman is the Kimmel Professor of Molecular Immunology at NYU School of Medicine, with expertise in immunology and virology. He holds a BA from Princeton University and an MD and PhD from Washington University in St. Louis, and completed his residency and postdoctoral fellowship at Columbia University. He has co-founded biotechnology companies and received several awards in biomedical science.
Invests in
Biotech
Investments
Board seats
Pfizer, Inc.
Investor
ImmunaiVedanta Biosciences
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Network7
Investors connected to Dan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Dan Littman?
- Dan Littman is the Kimmel Professor of Molecular Immunology at NYU School of Medicine, with expertise in immunology and virology. He holds a BA from Princeton University and an MD and PhD from Washington University in St. Louis, and completed his residency and postdoctoral fellowship at Columbia University. He has co-founded biotechnology companies and received several awards in biomedical science.
- Where does Dan Littman work?
- Dan Littman is Venture Partner at Catalio Capital Management, LP.
- What does Dan Littman invest in?
- Dan Littman invests in Biotech.
- What check size does Dan Littman write?
- Dan Littman typically writes checks of $100K – $5M.
- What boards does Dan Littman sit on?
- Dan Littman holds tracked board seats at Pfizer, Inc..
- What companies has Dan Littman invested in?
- Investments tracked here include Immunai, Vedanta Biosciences.